The liver cancer often takes place the cirrhosis sufferer's body cause by hepatitis at the chronic C type, the cirrhosis patient has around annually 2 - 5% develop into liver cancer.At Japan, liver cancer the occurrence is at the chronic C type hepatitis ratio B type hepatitis many, in the past 10 years in have already increase 200%.And the dangerous rate of liver cancer occurrence is with the degree but increment of the cirrhosis severity, is relevant chronic C type hepatitis and cirrhosis the patient accept an interferon treatment of the research discover, C type hepatitis merger cirrhosis the patient causes with the interferon treatment the probability of liver cancer the ratio have no interferon treatment to reduce.While having not made progress into cirrhosis such as the chronic C type hepatitis carrier accept an interferon treatment, its curative effect then is better.But lose the cirrhosis of a Chang shouldn't then accept an interferon treatment, should consider liver transplantation.
Japan at the earliest stage in 1995 announce an interferon treatment can lower the research that the chronic C type hepatitis causes liver cancer.This research show that cure by interferon for 3-6 months, regardless the patient's liver function have have no improvement, Be track by 4 years, discover an usage interferon a treatment only 4% liver cancer happen, didn't accept an interferon but have 25% occurrence liver cancer.Immediately after a lot of researches confirm a this kind result.There is a nation plan in Japan, compare 2400 accept interferon treatment and 490 didn't accept an interferon treatment of C type hepatitis sufferer, the one who discover to accept an interferon treatment, the incidence rate of its liver cancer significantly lowers.Japan is moreover a large the research totally has 1022 chronic C type a hepatitis patient, accept an interferon treatment, equally track for 3 years, there are 54 contracting liver cancer, among them have complete reaction to the interferon the incidence rate of its liver cancer only 4.3%, the brief respond the incidence rate of its liver cancer then has never respond for 4.7% is 26.1%.Moreover a research discover the interferon can lower the incidence rate of liver cancer to reach to 13% and lower death rate to reach to 16%.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment